DNTH SG&A Expense Growth

Dianthus Therapeutics Inc · SG&A Expense Growth

DNTH logo

DNTH SG&A Expense Growth

Latest reported37.36%
DNTH FY SG&A Growth (YoY) (0.00% → 37.36%)
High-resolution chart · PNG

DNTH sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Dianthus Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
37.357%
37.6397%
169.3015%
244.7342%
-93.0359%
18.2063%
33.8799%
138.1643%
114.1379%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.